I agree that this site is using cookies. You can find further informations here.
X
Mansbach, Hank
49  results:
Search for persons X
?
1

OS-118 Week 48 results from the phase 2b ENLIVEN extension ..:

Loomba, Rohit ; Abdelmalek, Manal F. ; Kowdley, Kris V....
Journal of Hepatology.  80 (2024)  - p. S72 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Letter: Severe underweight and sarcopenia in decompensated ..:

Alkhouri, Naim ; Tseng, Leo ; Balic, Kemal..
Alimentary Pharmacology & Therapeutics.  59 (2024)  6 - p. 797-798 , 2024
Link: https://doi.org/10.1111/..
 
?
3

SAT-203 Pegozafermin added to background GLP-1 therapy in p..:

Sanyal, Arun J. ; Abdelmalek, Manal F. ; Kowdley, Kris V....
Journal of Hepatology.  80 (2024)  - p. S607-S608 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Author Correction: The FGF21 analog pegozafermin in severe ..:

Bhatt, Deepak L. ; Bays, Harold E. ; Miller, Michael...
Nature Medicine.  30 (2024)  6 - p. 1788-1789 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Pegozafermin Added to Background GLP-1 Therapy Led to Great..:

Loomba, Rohit ; Sanyal, Arun J. ; Gottwald, Mildred D....
Metabolism.  153 (2024)  - p. 155874 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Pegozafermin, a FGF21 Analog, for the Treatment of Non-alco..:

Bhatt, Deepak L. ; Sanyal, Arun J. ; Harrison, Stephen A....
Metabolism.  153 (2024)  - p. 155873 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Clinical trial: Effects of pegozafermin on the liver and on..:

Alkhouri, Naim ; Lazas, Donald ; Loomba, Rohit...
Alimentary Pharmacology & Therapeutics.  58 (2023)  10 - p. 1005-1015 , 2023
Link: https://doi.org/10.1111/..
 
?
8

The FGF21 analog pegozafermin in severe hypertriglyceridemi..:

Bhatt, Deepak L. ; Bays, Harold E. ; Miller, Michael...
Nature Medicine.  29 (2023)  7 - p. 1782-1792 , 2023
Link: https://doi.org/10.1038/..
 
?
9

Pegozafermin inhibits NASH-induced hepatocellular carcinoma..:

Margalit, Maya ; Rosenstock, Moti ; Tseng, Leo...
Journal of Hepatology.  78 (2023)  - p. S544 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Pegozafermin Led to Significant Metabolic Benefits, in Addi..:

Alkhouri, Naim ; Loomba, Rohit ; Frias, Juan P....
Metabolism.  142 (2023)  - p. 155455 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Pegozafermin for the Treatment of Severe Hypertriglyceridem..:

Bhatt, Deepak L. ; Bays, Harold E. ; Miller, Michael...
Metabolism.  142 (2023)  - p. 155456 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Pegozafermin Improved Liver Histology, Liver-related Non-in..:

Loomba, Rohit ; Alkhouri, Naim ; Feng, Shibao...
Metabolism.  142 (2023)  - p. 155454 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Pegozafermin for the treatment of non-alcoholic steatohepat..:

Loomba, Rohit ; Sanyal, Arun ; Kowdley, Kris...
Journal of Hepatology.  78 (2023)  - p. S14-S15 , 2023
Link: https://doi.org/10.1016/..
 
?
14

† Pegozafermin for the Treatment of Severe Hypertriglycerid..:

Bhatt, Deepak L ; Hartsfield, Cynthia L ; Bays, Harold E...
Journal of Clinical Lipidology.  17 (2023)  4 - p. e47-e48 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Population Pharmacokinetics and Pharmacodynamics of Pegozaf..:

Tseng, Chih‐Ming Leo ; Balic, Kemal ; Charlton, R. Will...
Clinical Pharmacology & Therapeutics.  114 (2023)  6 - p. 1323-1331 , 2023
Link: https://doi.org/10.1002/..
 
1-15